Director - Medical, CMH, Türkiye at Eli Lilly and Company

Istanbul, Istanbul, Turkiye

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, HealthcareIndustries

Requirements

Advanced degree (MD) in health sciences
Minimum 3 years of relevant clinical, therapeutic experience or relevant scientific industry experience
Cardiometabolic Health experience preferred
Good planning and organization skills
Strong communication skills
Ability to effectively partner across multiple functions
Advanced interpersonal, project management and presentation skills
Fluent in English (both verbal and written)
Ability to ‘translate’ scientific data into meaningful, clear, and compliant content for customer communications and engagement
Commercial/business acumen
Location: Based in Istanbul

Responsibilities

Serve as a key medical point of contact for the brand team
Contribute clinical, scientific, and strategic input to support the cross functional team
Contribute to the development (local materials) and/or review (global/regional materials) of promotional materials for the brand teams by offering scientific and creative input
Effectively communicate and transfer knowledge of the therapeutic available solutions environment, the clinical landscape and relevant medical and scientific information
Support the medical training needs of internal business partners such as sales and marketing
Support the planning & implementation of symposia, advisory boards, scientific exchange, and educational meetings/events with HCP’s
Respond to external customer questions and needs, including escalations by Med Info & sales in accordance with company-wide requirements for responding to unsolicited requests for information
Coordinate local activities and engagement of Thought Leaders
Develop and maintain collaborations and relationships with relevant professional societies
Deliver scientific, educational, and promotional presentations internally and to customers
Collaborate cross-functionally to drive improvement in customer engagement through Digital innovation
Oversee the collation and analysis of customer information to drive understanding and insights
Develop and/or contribute to the affiliate / therapeutic area medical plan and strategies
Support data analysis and the development of slide sets and publications (abstracts, posters, manuscripts)
Keep up to date with medical and other scientific developments relevant to the product or portfolio
Be aware of current trends, issues and projections for clinical practice and access
Partner with other existing medical affairs roles to achieve a seamless medical team aimed at delivering exceptional customer experiences
May serve as the affiliate medical/scientific leader including research and regulatory deliverables

Skills

Medical Affairs

Brand Team Support

Medical Launch

Scientific Communication

Thought Leader Engagement

Speaker Training

HCP Engagement

Advisory Boards

Symposia Planning

Customer Engagement

Digital Innovation

Cross-Functional Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free